Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002
Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002
Enrolling by invitation · NCT06262399 · Registry updated 2025-11-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hereditary Complement Deficiency Diseases, Hypersensitivity, Immediate, Primary Immunodeficiency Diseases, Skin and Connective Tissue Diseases, angioedema, cardiovascular disorder, hereditary angioedema, hereditary disease, immune system disorder, inborn error of immunity, skin disorder, skin vascular disease, urticaria, vascular disorder | Enrolling by invitation | Not stated | 2025-11-28 | NCT06262399 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Intellia Therapeutics | 7 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital | Cambridge | United Kingdom | 1 |
| Campbelltown Hospital | Campbelltown | Australia | 12 |
| Centre National de Reference - Grenoble | Grenoble | France | 1 |
| Charite-Universitätsmedizin Berlin | Berlin | Germany | 1 |
| Hôpital Claude Huriez | Lille | France | 6 |
| New Zealand Clinical Research | Auckland | New Zealand | 6 |
| University of Amsterdam Academic Medical Center | Amsterdam | Netherlands | 1 |